What Researchers Did
Researchers conducted a review of existing literature on hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for chronic, non-healing wounds.
What They Found
They found that hyperbaric oxygen therapy (HBOT) aids in the healing of ulcerated wounds and reduces the risk of amputation in diabetic patients. However, the precise biological mechanisms by which HBOT promotes wound repair, such as up-regulation of angiogenesis and collagen synthesis, are not fully understood, leading to empirical treatment protocols.
What This Means for Canadian Patients
Canadian patients with chronic, non-healing wounds, particularly those with diabetes, may benefit from hyperbaric oxygen therapy as an additional treatment option to promote healing and potentially prevent amputations. However, given the unclear biological mechanisms, treatment protocols may vary, and patients should discuss the evidence and potential benefits with their healthcare providers.
Canadian Relevance
This review does not have a direct Canadian connection.
Study Limitations
A key limitation is the lack of clarity regarding the precise biological mechanisms by which hyperbaric oxygen therapy promotes wound healing, leading to empirical treatment protocols.